US00218A1051 - Common Stock
ASP ISOTOPES INC
NASDAQ:ASPI (5/3/2024, 7:00:01 PM)
After market: 3.79 +0.07 (+1.88%)3.72
+0.31 (+9.09%)
ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. The company is headquartered in Washington, Washington Dc and currently employs 46 full-time employees. The company went IPO on 2022-11-10. The firm has a license to use technology, the Aerodynamic Separation Process (ASP technology), originally developed and licensed to it by Klydon Proprietary Ltd (Klydon), for the production, distribution, marketing and sale of all isotopes. Its initial focus is on the production and commercialization of enriched Carbon-14 (C-14), Molybdenum-100 (Mo-100) and Silicon-28 (Si-28). The company also intends to develop the ASP technology to produce enriched Uranium-235 (U-235). The company operates principally through subsidiaries: ASP Isotopes Guernsey Limited, which is focused on the development and commercialization of high value, low volume isotopes for highly specialized end markets; Enriched Energy LLC, which is focused on the development and commercialization of uranium for the nuclear energy market, and ASP Isotopes UK Ltd, which is the licensee of the ASP technology under the license agreement with Klydon.
ASP ISOTOPES INC
1101 Pennsylvania Avenue Nw, Suite 300
WASHINGTON WASHINGTON DC
P: 12027562245
Employees: 46
Website: https://aspisotopes.com/
ASP Isotopes just reported results for the fourth quarter of 2023.
WASHINGTON, April 11, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI (
The Company believes the structure of this transaction will result in substantially less fees, costs and dilution than may occur in alternative capital raising transactions, such as an underwritten offering or a private placement priced at a discount
The Company believes the structure of this transaction will result in substantially less fees, costs and dilution than may occur in alternative capital...
The contract focuses on preliminary engineering design and planning for an enrichment facility for the production of next generation nuclear fuels, and has an aggregate contract value of up to $2 million
Here you can normally see the latest stock twits on ASPI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: